Goldman Sachs Fund Complex > Goldman Sachs ETF Trust
Goldman Sachs Future Health Care Equity ETF
$107.19M
Avg Monthly Net Assets
$25.47M
Total Assets
$16K
Total Liabilities
$25.46M
Net Assets
Goldman Sachs Future Health Care Equity ETF is an Exchange-Traded Fund in Goldman Sachs ETF Trust
from Goldman Sachs Fund Complex,
based in New York,
United States of America.
The fund has one share class
and monthly net assets of $107.19M.
On July 29th, 2024 it reported 43 holdings, the largest
being Eli Lilly & Co (11.0%), AstraZeneca PLC (6.4%) and Novo Nordisk A/S (6.4%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| Goldman Sachs Future Health Care Equity ETF | C000228400 | ARCX | GDOC |
Holdings
From latest NPORT-P, filed July 29th, 2024 for period ending May 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| AbbVie Inc | Long | Equity-common | US | $1M | 7K | 4.19 |
| Agilent Technologies Inc | Long | Equity-common | US | $472K | 4K | 1.85 |
| Align Technology Inc | Long | Equity-common | US | $291K | 1K | 1.14 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $171K | 1K | 0.67 |
| Amgen Inc | Long | Equity-common | US | $1M | 4K | 4.69 |
| Argenx SE | Long | Equity-common | NL | $332K | 894 | 1.30 |
| AstraZeneca PLC | Long | Equity-common | GB | $2M | 11K | 6.43 |
| Biogen Inc | Long | Equity-common | US | $789K | 4K | 3.10 |
| BioMarin Pharmaceutical Inc | Long | Equity-common | US | $697K | 9K | 2.74 |
| Boston Scientific Corp | Long | Equity-common | US | $2M | 21K | 6.21 |
| CG oncology Inc | Long | Equity-common | US | $162K | 5K | 0.64 |
| Cooper Cos Inc/The | Long | Equity-common | US | $875K | 9K | 3.44 |
| CSL Ltd | Long | Equity-common | AU | $724K | 4K | 2.84 |
| Danaher Corp | Long | Equity-common | US | $950K | 4K | 3.73 |
| Dexcom Inc | Long | Equity-common | US | $412K | 3K | 1.62 |
| Edwards Lifesciences Corp | Long | Equity-common | US | $289K | 3K | 1.13 |
| Eli Lilly & Co | Long | Equity-common | US | $3M | 3K | 11.01 |
| Genmab A/S | Long | Equity-common | DK | $189K | 7K | 0.74 |
| Goldman Sachs Financial Square Treasury Obligations Fund | Long | Short-term investment vehicle | US | $227K | 227K | 0.89 |
| Hoya Corp | Long | Equity-common | JP | $486K | 4K | 1.91 |
| Humana Inc | Long | Equity-common | US | $804K | 2K | 3.16 |
| IDEXX Laboratories Inc | Long | Equity-common | US | $449K | 903 | 1.76 |
| Illumina Inc | Long | Equity-common | US | $104K | 994 | 0.41 |
| Insulet Corp | Long | Equity-common | US | $813K | 5K | 3.19 |
| Intra-Cellular Therapies Inc | Long | Equity-common | US | $137K | 2K | 0.54 |
| Intuitive Surgical Inc | Long | Equity-common | US | $1M | 3K | 4.75 |
| iRhythm Technologies Inc | Long | Equity-common | US | $103K | 1K | 0.41 |
| Kyowa Kirin Co Ltd | Long | Equity-common | JP | $222K | 13K | 0.87 |
| Lonza Group AG | Long | Equity-common | CH | $528K | 979 | 2.07 |
| Mettler-Toledo International Inc | Long | Equity-common | US | $739K | 526 | 2.90 |
| MoonLake Immunotherapeutics | Long | Equity-common | CH | $112K | 3K | 0.44 |
| Natera Inc | Long | Equity-common | US | $149K | 1K | 0.59 |
| Neurocrine Biosciences Inc | Long | Equity-common | US | $667K | 5K | 2.62 |
| Novo Nordisk A/S | Long | Equity-common | DK | $2M | 12K | 6.42 |
| Roivant Sciences Ltd | Long | Equity-common | US | $136K | 13K | 0.53 |
| Sartorius Stedim Biotech | Long | Equity-common | FR | $156K | 786 | 0.61 |
| Shockwave Medical Inc | Long | Equity-common | US | $439K | 1K | 1.72 |
| Ultragenyx Pharmaceutical Inc | Long | Equity-common | US | $140K | 3K | 0.55 |
| Vaxcyte Inc | Long | Equity-common | US | $174K | 2K | 0.68 |
| Veeva Systems Inc | Long | Equity-common | US | $284K | 2K | 1.12 |
| West Pharmaceutical Services Inc | Long | Equity-common | US | $181K | 547 | 0.71 |
| Xenon Pharmaceuticals Inc | Long | Equity-common | CA | $114K | 3K | 0.45 |
| Zimmer Biomet Holdings Inc | Long | Equity-common | US | $805K | 7K | 3.16 |
Address
Goldman Sachs ETF Trust
200 West Street
New York
New York
10282
United States of America
Websites
Directors
Lawrence Hughes
Lawrence W. Stranghoener
James A. McNamara
Cheryl K. Beebe
Steven D. Krichmar
Michael Latham
John F. Killian
Transfer Agents
BNY Mellon Investment Servicing (US) Inc.
Pricing Services
Thomson Reuters Corporation
Custodians
Federal Reserve Bank of New York
The Bank of New York Mellon
The Depository Trust Company
The Bank of New York Mellon (United Kingdom)
Euroclear Bank
Shareholder Servicing Agents
The Bank of New York Mellon
Admins
The Bank of New York Mellon
Goldman Sachs Asset Management, L.P
Brokers
N/A